Effect of curcumin on intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats

Journal of Medicinal Food

Volumn 10, Issue 3, 2007, Pages 486-494

  Kumar, Anil ^a   Naidu, P S ^a   Seghal, N ^a   Padi, S S V ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Cognitive impairment; Colchicine; Curcumin; Oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; COLCHICINE; CURCUMIN; GLUTATHIONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; LEARNING; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

ACETYLCHOLINESTERASE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN CHEMISTRY; CEREBRAL VENTRICLES; COGNITION DISORDERS; COLCHICINE; CURCUMIN; GLUTATHIONE; LIPID PEROXIDATION; MALE; MAZE LEARNING; MEMORY; NITRITES; OXIDATIVE STRESS; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 34848840946     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.076     Document Type: Article

References (42)

1. Bartus RT, Dean RL, Poontecarvo MJ, Flicker C: The cholinergic hypothesis: historical overview, current perspective and future perspective. Ann NY Acad Sci 1985;444:332-358.
2. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeIon MR: Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-1239.
3. Pratico D, Norman D: Oxidative injury in disease of central nervous system: focus on Alzheimer's disease. Am J Med 2000;109:577-585.
4. Pratico D: Alzheimer's disease and oxygen radicals: new insights. Biochem Pharmacol 2002;63:563-567.
5. Sambamurti K, Greig NH, Lahiri DK: Advances in the cellular and molecular biology of the beta amyloid protein in Alzheimer's disease. Neuromol Med 2002;1:1-31.
6. Simonian NA, Coyle JT: Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996;36:83-106.
7. Slikker W, Youdim MB, Palmer GC, Hall E, Williams C, Trembley B: The future of neuroprotection. Ann NY Acad Sci 1999;890:135-172.
8. Vina J, Lloret A, Orti R, Alonso D: Molecular basis of treatment of Alzheimer's disease with antioxidants. Mol Aspects Med 2004;25:117-123.
9. Ganguli M, Chandra V, Kamboli MI, et al.: Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross National Dementia study. Arch Neurol 2000;57:824-830.
10. Ammon HPT, Wahl MA: Pharmacology of Curcuma longa. Planta Med 1990;57:1-7.
11. Noguchi N, Komue E, Niki E, Willson RL: Action of curcumin as an antioxidant against lipid peroxidation. Yukagaku Zasshi 1994;43:1045-1051.
12. Sreejayan N, Rao MNA: Free radical scavenging activity of curcuminoids. Arzneimittelforschung 1996;46:838-843.
13. Kalpana C, Rajasekharan KN, Menon VP: Modulatory effects of curcumin and curcumin analog on circulatory lipid profiles during nicotine-induced toxicity in Wistar rats. J Med Food 2005;8:246-250.
14. Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ: Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 1989;14:175-185.
15. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM: The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer trangenic mouse. J Neurosci 2001;21:8370-8377.
16. Rajakrishnan V, Viswanathan P, Rajasekharan KN, Menon VP: Neuroprotective role of curcumin from Curcuma longa on ethanol-induced brain damage. Phytother Res 1999;13:571-574.
17. Emerich DF, Walsh TJ: Cholinergic loss and cognitive impairment following intraventricular or intradentate injections of colchicine. Brain Res 1990;517:157-167.
18. Nakagawa YS, Nakamura S, Kase Y, Noguchi T, Ishihara T: Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease. Brain Res 1987;408:57-64.
19. Veerendra Kumar MH, Gupta YK: Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats. Pharmacol Biochem Behav 2002;73:565-571.
20. Ceccatelli S, Ahlbom E, Diana A, Zhivotovsky B: Apoptosis in rat hippocampal dentate gyrus after intraventricular colchicine. Neuroreport 1997;8:3779-3783.
21. Nakayama T, Sawada T: Involvement of microtubule integrity in memory impairment caused by colchicine. Pharmacol Biochem Behav 2002;71:119-138.
22. Verma A, Kulkarni SK: Evaluation of learning and memory mechanisms employing plus maze in rats and mice. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:117-125.
23. Wills ED: Mechanism of lipid peroxide formation in animal. Biochem J 1966;99:667-676.
24. Ellman GL, Courtney KD, Andres V, Featherstone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
25. 15N] nitrate in biological fluids. Ann Biochem 1982;126:131-138.
26. Mahesh T, Balasubashini MS, Menon VP: Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. J. Med Food 2005;8:251-255.
27. Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Danshary ES: Protective effects of curcumin against ischemia-reperfusion insult in rat forebrain. Pharmacol Res 2002;46:273-279.
28. Vajragupta O, Boonchong P, Watanabe H, Tohda M, Kummasud N, Sumanont Y: Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity. Free Radic Biol Med 2003;35:1632-1644.
29. Sreejayan N, Rao MNA: Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 1994;46:1013-1016.
30. Kunchandy F, Rao MNA: Oxygen radical scavenging activity of curcumin. Int J Pharm 1990;58:237-240.
31. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S: Through metal binding, curcumin protects against lead and cadmium induced lipid peroxidation in rat brain homogenates and against lead induced tissue damage in rat brain. J Inorg Biochem 2004;98:266-275.
32. Kunchandy F, Rao MNA: Oxygen radical scavenging activity of curcumin. Int J Pharm 1990;58:237-240.
33. Rukkumani R, Aruna K, Varma PS, Rajasekaran KN, Menon VP: Comparative effects of curcumin and its analog on alcohol- and polyunsaturated fatty acid-induced alterations in circulatory lipid profiles. J Med Food 2005;8:256-260.
34. Susan M, Rao MNA: Induction of glutathione-S-transferase activity by curcumin in mice. Drug Res 1992;42:962-964.
35. Chan MM, Huang HI, Fenton MR, Fong D: In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with antiinflammatory properties. Biochem Pharmacol 1998;55:1952-1962.
36. Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ: Curcumin inhibits cyclooxygenase-2 transcription in bile acid and phorbol ester treated human gastrointestinal epithelial cells. Carcinogenesis 1999;20:445-451.
37. Frautschy SA, Hu W, Kim P, et al.: Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiol Aging 2001;22:993-1005.
38. Zhu YG, Chen XC, Chen ZZ, et al.: Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. Acta Pharmacol Sin 2004;25:1606-1612.
39. Palmer HJ, Paulson KE: Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev 1997;55:353-361.
40. 2 for PGDF signal transduction. Science 1995;270:296-299.
41. Chen RW, Qin ZH, Ren M, et al.: Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection. J Neurochem 2003;84:566-575.
42. Yang F, Lim GP, Begum AN, et al.: Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005;280:5892-5901.